Search research articles
Contact Us
Filters
Showing results (21-30 of 73) with videos related to
Page
of 8
Sort By:
Human Pathology
|
February 15, 2011
Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome
Ben Davidson, Arild Holth, Leni Moripen, et al.
Human Pathology
|
January 23, 2009
Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival
Ben Davidson, Rivka Hadar, Helene Tuft Stavnes, et al.
Gynecologic Oncology
|
August 22, 2006
The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma
Michal Gorovetz, Mark Baekelandt, Aasmund Berner, et al.
BMC Cancer
|
October 30, 2013
Primary tumor vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact
Hari Prasad Dhakal, Jahn M Nesland, Mette Førsund, et al.
Histology and Histopathology
|
October 2, 2010
New determinates of disease progression and outcome in metastatic ovarian carcinoma
Ben Davidson, Reuven Reich, Claes G Trope, et al.
Plos One
|
April 13, 2013
Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma
Ruth Holm, Mette Førsund, Mai T Nguyen, et al.
Human Pathology
|
March 30, 2007
Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions
Ben Davidson, Aasmund Berner, Claes G Trope', et al.
Human Pathology
|
August 23, 2011
Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival
Kjersti Brenne, Dag André Nymoen, Thea Eline Hetland, et al.
Journal of Cellular and Molecular Medicine
|
August 19, 2010
miRNA profiling along tumour progression in ovarian carcinoma
Olga Vaksman, Helene Tuft Stavnes, Janne Kaern, et al.
BMC Cancer
|
July 8, 2015
The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study
Ruixia Huang, Xiaoran Li, Ruth Holm, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 73) with videos related to
Sort By:
Page
of 8
Human Pathology
|
February 15, 2011
Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome
Ben Davidson, Arild Holth, Leni Moripen, et al.
Human Pathology
|
January 23, 2009
Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival
Ben Davidson, Rivka Hadar, Helene Tuft Stavnes, et al.
Gynecologic Oncology
|
August 22, 2006
The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma
Michal Gorovetz, Mark Baekelandt, Aasmund Berner, et al.
BMC Cancer
|
October 30, 2013
Primary tumor vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact
Hari Prasad Dhakal, Jahn M Nesland, Mette Førsund, et al.
Histology and Histopathology
|
October 2, 2010
New determinates of disease progression and outcome in metastatic ovarian carcinoma
Ben Davidson, Reuven Reich, Claes G Trope, et al.
Plos One
|
April 13, 2013
Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma
Ruth Holm, Mette Førsund, Mai T Nguyen, et al.
Human Pathology
|
March 30, 2007
Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions
Ben Davidson, Aasmund Berner, Claes G Trope', et al.
Human Pathology
|
August 23, 2011
Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival
Kjersti Brenne, Dag André Nymoen, Thea Eline Hetland, et al.
Journal of Cellular and Molecular Medicine
|
August 19, 2010
miRNA profiling along tumour progression in ovarian carcinoma
Olga Vaksman, Helene Tuft Stavnes, Janne Kaern, et al.
BMC Cancer
|
July 8, 2015
The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study
Ruixia Huang, Xiaoran Li, Ruth Holm, et al.
Page
of 8